New Wave Ventures LLP was formed as a vehicle for the personal business investments of its founders, Paul Newey and Tim Bullock. New Wave has no external investors or investment committee and addresses each investment opportunity with an open mind – aiming to achieve the most satisfactory structure for all. New Wave’s preference is to invest in high quality management teams with a strongly differentiated product and the potential to make a significant impact on markets with global scale.
Sarum Capital is an advisor to Sarum Investment SIVAC plc which is an oncology focused venture fund investing in primarily private European cancer related businesses. This fund gives exposure to all sectors of the cancer industry from from diagnostics and medtech through to therapeutics and aftercare, and supports companies that it considers to have the highest potential for solid growth and success.
UCL Business PLC is responsible for commercialising innovations arising from the research base at University College London, one of the UK’s leading research-led universities. UCL Business undertakes a broad range of knowledge transfer activities, covering the facilitation of consultancy and collaborative research engagements, through to technology transfer, company incubation and investment.
Sussex Place Ventures is owned by the London Business School, and is positioned to leverage the Business School’s alumni base and associated entrepreneurial cluster. Sussex Place Ventures invests from two funds: Regents Park Partners LP, a private investor fund which was raised in August 2007 and invests in venture capital and smaller private equity deals, and the Combined London Colleges University Challenge Fund, a University-based seed fund.
The Bloomsbury BioSeed Fund was also established as part of the UK Government’s University Challenge Seed Fund initiative, with University College London, Cancer Research Technology, Institute of Cancer Research, the School of Pharmacy, the London School of Hygiene and Tropical Medicine and the Royal Veterinary College as partners in the £4 million fund. The objective of BBSF was to create new high growth companies within the areas of Life Sciences arising from projects originating within the member research institutes.